Can Veinlite Reduce Complications of Peripheral Intravenous Catheter Placement in Children
NCT ID: NCT05242068
Last Updated: 2022-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
139 participants
INTERVENTIONAL
2018-12-01
2020-01-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators' hypothesis for this study was that the vein imaging would reduce the complications related to catheter and the pain that the participants would feel.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vein Imaging Device on First-Attempt Success in Peripheral Intravenous Catheter Insertion
NCT07006038
Interest of Peripheral Venous Catheter Insertion Using a Micro-guide in Neonatology
NCT04984967
A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children
NCT05204082
The Effect of the Vein Imaging Device Used in Peripheral Intravenous Catheter Application on the Success of the Procedure in Patients Coming to the Pediatric Emergency Department
NCT06233214
"Syringe Free" Long-Axis In-Plane vs. Short-Axis Out-of-Plane Approach for Central Venous Catheter Placement
NCT04684069
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary endpoint was to evaluate whether Veinlite LED+ would prevent catheter-related complications.
The secondary endpoint were;
1. to evaluate the efficacy of the vein imaging device on pediatric pain during intravenous catheterization
2. to evaluate the efficacy of the vein imaging device on catheter dwell time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard care of group
Patients in standard care of group received traditional peripheral intravenous catheterization
Standard care
Patients received standard intravenous catheterization.
Veinlite group
Patients in veinlite group received peripheral intravenous catheterization with Veinlite
Veinlite
Use of vein imaging device for visualization of veins during peripheral IV placement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Veinlite
Use of vein imaging device for visualization of veins during peripheral IV placement
Standard care
Patients received standard intravenous catheterization.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children with DIVA (Difficult intravenous access score) score 4 or more
* That the child and the parent speak Turkish
Exclusion Criteria
* a critical health condition
* That the child or the parent has a communication problem
5 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayşe Kahraman
associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ege University
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E.314064
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.